Irish Life Investment Managers’s Celldex Therapeutics CLDX Stock Holding History

Irish Life Investment Managers’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$67.1K	Buy	+287	New	+$56.5K	﹤0.01%	1145

Other funds holding CLDX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Irish Life Investment Managers's CLDX Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Celldex Therapeutics (CLDX) in Q2 2013: 287 shares worth $67.1K. The stake represents ﹤0.01% of the portfolio and ranks #1145 among its holdings.

129 funds tracked by Wall St. Rank hold CLDX as of Q2 2013.

Irish Life Investment Managers held 287 shares of Celldex Therapeutics worth $67.1K as of Q2 2013.
Celldex Therapeutics was a new Irish Life Investment Managers position in Q2 2013.
Celldex Therapeutics made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1145 holding.
129 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.